Article
The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
Transfusion - 1 Feb 2020
Hindawi Salwa, Badawi Maha, Elfayoumi Refaat, Elgemmezi Tarek, Al Hassani Abrar, Raml Mohamed, Alamoudi Seraj, Gholam Kholoud
Abstract excerpt
BACKGROUND: Blood transfusion is the first-line treatment for patients with thalassemia and many sickle cell patients. However, cases of unregulated blood transfusion are shown to carry a high risk of alloimmunization to red blood cells (RBCs), which can lead to a hemolytic transfusion reaction and be fatal to patients. Screening and identification of alloantibodies are, therefore, essential practice in blood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.